Definitive Contract HHSN268200800003C
- Not listed
- The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $18,371.00 firm-fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract is for the NHLBI's DIR Graft Lungevity Study, which requires obtaining samples and data. The contract has an ultimate completion date of August 31, 2025 and was awarded on September...
- This is a federal contract award from the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract, valued at $1,677,614.67, is for the Gene Therapy Resource Program (GTRP), which supports translational gene therapy research by providing resources and services from three core laboratories: the Pharmacology and Toxicology Core Laboratory, the...
- This $14,424.00 firm fixed-price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The award, which does not have a set-aside designation, is described as QTE#27207 and has an ultimate completion date of August 11, 2023. The University of Pennsylvania is a renowned private...
- This is a $10,523 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract is for tuition assistance and does not have a set-aside designation. The University of Pennsylvania is a renowned private research university and academic medical center that has a substantial portfolio of federal contracts and grants...
- This is a $10,523 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to The Trustees of the University of Pennsylvania (Penn), doing business as the Clinical Practices of the University of Pennsylvania. The contract is for tuition assistance and does not have a set-aside designation. Penn is a renowned private research university and academic medical center that conducts a wide range of research and provides various services to the federal...
- This is a $150,000.00 grant award to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, for a research program to execute a balanced science program based on guidance from the National Academies of Sciences, Engineering, and Medicine, administration priorities, and direction from Congress. The award is from a civilian federal agency, the Shared Services Center, and does not have a set-aside designation. The University of...
- This contract award to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, is for a Phase I single and multiple-dose safety and pharmacokinetic clinical study of Bowman-Birk Inhibitor Concentrate, with a total ceiling value of $6,199,624.00. The contract is a definitive Cost No Fee contract with a period of performance through December 29, 2009. The place of performance is in Philadelphia, PA. This contract award does not...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The $16,000.00 contract is for "other functions" in support of Pennsylvania University, and does not have a set-aside designation. The University of Pennsylvania is a...
- This is a $10,523 firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. government, to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract, which does not have a set-aside designation, is for non-federal tuition and registration fees. The University of Pennsylvania is a renowned private research university and academic medical center that provides a wide...
- This $45,847.46 firm-fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to The Trustees of the University of Pennsylvania (Penn), a private university and non-profit organization, on September 15, 2019. The contract is for a study-related analysis effort with a completion date of September 14, 2023. Penn has a history of receiving federal contracts and grants from agencies such as the Department of Defense, NASA, National Institutes...
This is a definitive cost-no-fee contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian federal agency, to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The $12,427,447.18 contract is for a randomized clinical trial of genotype-guided dosing of warfarin therapy. The contract does not have a set-aside designation, reflecting the University of Pennsylvania's status as a large research institution. As a renowned private research university and academic medical center, the University of Pennsylvania has a long history of conducting cutting-edge research and providing services to the federal government under contracts and grants. This specific contract supports NHLBI's research objectives by providing critical clinical data to advance medical countermeasures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 12 | Other Administrative Action | ($937k) | 3/19/15 | |
| 11 | Other Administrative Action | $0 | 3/24/14 | |
| 10 | Other Administrative Action | $0 | 2/3/14 | |
| 9 | Exercise an Option | $437.0k | 7/8/13 | |
| 8 | Other Administrative Action | $0 | 6/18/13 |